Q1 EPS Forecast for Monogram Orthopaedics Reduced by Analyst

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Research analysts at Roth Capital dropped their Q1 2025 earnings per share estimates for shares of Monogram Orthopaedics in a research note issued to investors on Wednesday, April 16th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of ($0.13) per share for the quarter, down from their prior estimate of ($0.10). The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.13) EPS, Q3 2025 earnings at ($0.13) EPS, Q4 2025 earnings at ($0.42) EPS, FY2025 earnings at ($0.81) EPS, Q1 2026 earnings at ($0.14) EPS, Q2 2026 earnings at ($0.14) EPS, Q3 2026 earnings at ($0.12) EPS, Q4 2026 earnings at ($0.32) EPS, FY2026 earnings at ($0.73) EPS, FY2027 earnings at ($0.34) EPS and FY2028 earnings at $0.02 EPS.

Separately, Roth Mkm upped their target price on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the company a “buy” rating in a report on Tuesday, March 18th.

Monogram Orthopaedics Price Performance

Monogram Orthopaedics stock opened at $2.70 on Friday. The stock has a market capitalization of $95.28 million, a PE ratio of -5.74 and a beta of 0.77. The business’s fifty day moving average is $2.61 and its 200 day moving average is $2.50. Monogram Orthopaedics has a one year low of $1.82 and a one year high of $4.21.

Monogram Orthopaedics (NASDAQ:MGRM) last released its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.03.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in MGRM. Geode Capital Management LLC boosted its position in Monogram Orthopaedics by 7.7% during the 4th quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock valued at $537,000 after acquiring an additional 16,234 shares in the last quarter. Northern Trust Corp increased its stake in shares of Monogram Orthopaedics by 110.6% in the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after acquiring an additional 24,088 shares during the period. Commonwealth Equity Services LLC lifted its holdings in shares of Monogram Orthopaedics by 21.5% in the 4th quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock valued at $99,000 after buying an additional 7,366 shares during the period. Fiduciary Family Office LLC purchased a new stake in Monogram Orthopaedics during the fourth quarter worth $70,000. Finally, State Street Corp acquired a new position in Monogram Orthopaedics in the 3rd quarter worth about $62,000. Hedge funds and other institutional investors own 0.45% of the company’s stock.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.